Basic info
Industry
biotechnology research
Sectors
Biotechnology
Microreservoirs
Treatment
Uveal melanoma
Ocular
Health Care
Therapeutics
Anti-VEGF
Retinal inflammation
AMD
Retinoblastoma
Uveitis
Diabetic macular edema
OxuFlo
Ophthalmology
OxuLumis
Gene therapy
DME
Medical
Age-related Macular Degeneration
Retinal disease
Date founded
2014
Funding rounds raised
Total raised
$37M
from 7 investors over 7 rounds
O
Oxular raised $37M on March 1, 2021
Investors: V-Bio Ventures, IP Group plc and Forbion
O
Oxular raised $21M on July 19, 2016
Investors: Consort Medical Plc, V-Bio Ventures and Imperial College London
O
Oxular raised $19M on February 22, 2016
Investors: Imperial College London